advertisement

---

Kiyota N 17

Showing records 1 to 17 | Display all abstracts from Kiyota N

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Sato K
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kiyota N
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Mochida S
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Shiga Y
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tomimoto D
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Yasuda M
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Konuma T
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Aizawa N
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Kiyota N
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Omodaka K; Tsuda S
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tsuda S
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Pak K
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Shiga Y
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kunikata H
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Omodaka K
Experimental Eye Research 2020; 193: 107997

---

86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Nakazawa T
Acta Ophthalmologica 2020; 98: e747-e753

---

86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Nakazawa T
Experimental Eye Research 2020; 193: 107997

---